SMO and GLI1 gene expression levels, tumor site, patient's gender, and history of asbestos exposure were all risk factors for survival time in mesothelioma patients (P < 0.05), and the findings were consistent with greater significance for the prognostic value of mesothelioma. The gene discussed is GLI1; the disease is neoplasm.